| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Change in the fair value of obligation to issue shares | - | - | 1,880,911 | - |
| Total other income (expenses) | -542,165 | -572,478 | -22,894 | 686,367 |
| Net income (loss) | -1,477,811 | -1,413,458 | -690,594 | 188,421 |
| Foreign currency translation adjustment | 278,300 | -653,505 | -6,891 | -104,442 |
| Net comprehensive income (loss) | -1,199,511 | -2,066,963 | -697,485 | 83,979 |
| Diluted average shares | - | - | - | 662,501,405 |
| Basic and diluted income (loss) per share of common shares | 0 | 0 | 0 | 0 |
| Weighted average number of shares outstanding | 662,501,405 | 662,501,405 | 662,501,405 | - |
CANNAPHARMARX, INC. (CPMD)
CANNAPHARMARX, INC. (CPMD)